MOMM Diagnostics
PrivateLast Round
Grant
Jan 12, 2026
Total Funding Raised
$2.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MOMM Diagnostics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Grant round in January 2026.
MOMM Diagnostics is a medical technology company that develops rapid, point-of-care diagnostic tests for the early detection of preeclampsia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOMM Diagnostics Comparables
Compare MOMM Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lepzi | 84% | |
| Gravidas Diagnostics Inc. | 79% | |
| Modality Dx | 78% |
For institutional investors. Book with your work email.
MOMM Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 12, 2026 | ||||
| Grant | Oct 5, 2025 | ||||
| Seed | May 31, 2022 | ||||
| Grant | May 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MOMM Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Innosuisse | Seed |
| University of Basel | Seed |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased by 50% MoM.
- Jan 22, 2026
Monthly visitors increased 217% MoM.
For institutional investors. Book with your work email.
MOMM Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MOMM Diagnostics's valuation, stock price, and market status.
Is MOMM Diagnostics a public or private company?
MOMM Diagnostics is a private company.
What is the current stock price of MOMM Diagnostics?
MOMM Diagnostics is a private company, so its shares have no public market price. Caplight tracks MOMM Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MOMM Diagnostics worth (valuation)?
Valuation information for MOMM Diagnostics is not publicly available.
Can I buy MOMM Diagnostics stock?
MOMM Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MOMM Diagnostics's last funding round?
MOMM Diagnostics's most recent funding round was Grant on January 12, 2026.
Who are the main investors in MOMM Diagnostics?
Key investors in MOMM Diagnostics include Gates Foundation, Bill & Melinda Gates Foundation.
Will MOMM Diagnostics IPO soon?
No public IPO plans have been announced for MOMM Diagnostics.
How can I track MOMM Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in MOMM Diagnostics's shares on secondary markets.